Shawn David Roman
Chief Operating Officer · Apyx Medical Corp
Individual
- 2026
- Jun 17, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Shawn David Roman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- August J. Troendle - $358.45M in MEDP purchases and sales in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M in AVAH purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shawn David Roman?
Shawn David Roman is a corporate insider, tracked as Chief Operating Officer of Apyx Medical Corp (APYX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Shawn David Roman last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 3 filings going back to 2026.
